ArticleMedical hypotheses2020

Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents.

Ahmed Yaqinuddin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.